October 5, 2015
Detailing on MSD’s insomnia medicine Belsomra (suvorexant) left the strongest impression on physicians in July, according to a monthly survey conducted by the market research firm Anterio Inc. Belsomra climbed two notches from the previous month to overtake Takeda Pharmaceutical’s...read more